TRIB
Trinity Biotech PLC
$0.39
+0.00 (+0.00%)
At close · Jul 10
Market Cap
$7.83M
Shares
20,250,869
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.39
Open$0.39
Day$0.37–0.39
52W$0.31–3.44
Avg vol 30d2.6M
Short int1.4M · 7.0% float · 1.0d
Short vol28%
Last earningsSep 30, 2024
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−50%
below
Price vs 50-day avg
−31%
below
RSI (14)
36
neutral
MACD trend
Positive
52-week position
3%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−43%
trailing
6-month return
−45%
trailing
YTD return
−51%
this year
Relative strength
−54%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
4 of 25 funds reported for Jun 30 · net +32.9K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
7.00% of float · ▲ +878.7% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
25 holders — mid 2-yr range
Squeeze score
63
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
144%
annualized · 1-yr
Max drawdown
−82%
past year
ATR
15.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−50%
Bearish
Price vs 50-day avg
−31%
Bearish
RSI (14)
36
Neutral
MACD trend
Positive
Bullish
52-week position
3%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
4 of 25 funds reported for Jun 30 · net +32.9K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
7.00% of float · ▲ +878.7% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
25 holders — mid 2-yr range
Price context
position in its 52-week range
52-wk low $0
Now $0 · 3%
52-wk high $3
vs 200-day avg -50%
vs 50-day avg -31%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TRIB
this stock
Trinity Biotech PLC
|
$7.83M | -50.6% | — | — | 7.0% |
|
ABT
Abbott Laboratories
|
$163.61B | -24.7% | +5.7% | 26.3 | 1.3% |
|
SYK
Stryker Corp
|
$126.42B | -5.9% | +11.2% | 38.2 | 1.8% |
|
MDT
Medtronic plc
|
$107.36B | -12.0% | +8.4% | 22.5 | 1.5% |
|
BSX
Boston Scientific Corp
|
$66.54B | -53.0% | +5.5% | 18.7 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TRIB | +2.6% | -43.5% | -45.1% | +0.0% | -50.6% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | +1.3% | -47.6% | -54.1% | -1.1% | -61.3% |